John C Byrd

John C Byrd, MD is the Chairman of the Scientific Advisory Board of Vincerx and an internationally known researcher and clinical specialist in leukemia and other hematologic malignancies. Dr. Byrd is currently the Department Chair, The Gordon and Helen Hughes Taylor Professor, University of Cincinnati. Previously, he was the D Warren Brown Chair of Leukemia Research at the Ohio State University College of Medicine. At Ohio State University, Dr. Byrd is also a Distinguished University Professor, a permanent title that is the highest faculty honor at the university and is given to full professors who have demonstrated exceptional teaching, research, scholarly or creative work, and service. His primary appointment is in the College of Medicine’s Department of Internal Medicine, with secondary appointments in the Division of Pharmaceutics and Medicinal Chemistry in the College of Pharmacy and the Department of Veterinary Bioscience in the College of Veterinary Medicine. Additionally, he is director of the Clara Bloomfield Center for Prognosis in Myeloid Leukemia, senior advisor for cancer experimental therapeutics, and co-leader of the Leukemia Research Program at the Ohio State University Comprehensive Cancer Center. From 2010 until 2017, he served as director of the Division of Hematology.

Dr. Byrd received his medical degree in 1991 from the University of Arkansas for Medical Sciences. He did his internship and residency in internal medicine at the Walter Reed Army Medical Center in Washington, DC, and then completed a fellowship there in hematology, oncology, and bone marrow transplantation. Dr. Byrd also received a year of translational laboratory training at Johns Hopkins University.